Literature DB >> 30466555

Case definitions of hemolytic uremic syndrome following Escherichia coli O157:H7 infection vary in validity.

Gillian A M Tarr1, Hanna N Oltean2, Amanda I Phipps3, Peter Rabinowitz4, Phillip I Tarr5.   

Abstract

BACKGROUND: Multiple case definitions for post-diarrheal hemolytic uremic syndrome (D+ HUS) associated with Shiga toxin-producing Escherichia coli (STEC) are used across public health, research, and clinical practice.
METHODS: To identify a single definition of D+ HUS for standardized use, we evaluated the comparability and validity of four common, heterogeneous definitions: the Council of State and Territorial Epidemiologists (CSTE) definition, hematology-focused and age-focused definitions from the literature, and hospital diagnosis. We reviewed medical records from 471 hospitalized E. coli O157:H7 cases reported in Washington State, 2005-2014. We assessed 1) reliability across definitions, 2) comparability of temporal trends, and 3) sensitivity and specificity using an omnibus reference standard, developed using a combination of definition agreement and clinical outcomes. With the standard, we classified cases as definite, borderline, or unlikely/not post-diarrheal D+ HUS.
RESULTS: Reliability was highest between the age-focused definition and hospital diagnosis (κ = 0.84), and temporal trends were largely comparable across definitions. For definite D+ HUS cases, the age-focused definition had the highest overall validity [100% sensitivity, 95% confidence interval (CI): 94%, 100%; 96% specificity, 95% CI: 94%, 98%]. The CSTE definition had low specificity (75%, 95% CI: 70%, 79%).
CONCLUSIONS: In this review, the CSTE definition overestimated the burden of D+ HUS, and the age-focused definition provided the best overall reliability and validity to define post-diarrheal D+ HUS. Disease monitoring and research activities should consider using the age-focused D+ HUS definition.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  E. coli O157:H7; Hemolytic uremic syndrome; Shiga toxin-producing Escherichia coli; Surveillance

Mesh:

Year:  2018        PMID: 30466555      PMCID: PMC6260930          DOI: 10.1016/j.ijmm.2018.10.002

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  34 in total

Review 1.  Hemolytic uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157:H7 and other shiga toxin-producing E. coli.

Authors:  B E Mahon; P M Griffin; P S Mead; R V Tauxe
Journal:  Emerg Infect Dis       Date:  1997 Jul-Sep       Impact factor: 6.883

2.  Province-Wide Review of Pediatric Shiga Toxin-Producing Escherichia coli Case Management.

Authors:  Stephen B Freedman; Mohamed Eltorki; Linda Chui; Jianling Xie; Sharon Feng; Judy MacDonald; Andrew Dixon; Samina Ali; Marie Louie; Bonita E Lee; Lara Osterreicher; Jennifer Thull-Freedman
Journal:  J Pediatr       Date:  2016-10-10       Impact factor: 4.406

3.  Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome.

Authors:  Martina Bielaszewska; Alexander W Friedrich; Thomas Aldick; Robin Schürk-Bulgrin; Helge Karch
Journal:  Clin Infect Dis       Date:  2006-10-02       Impact factor: 9.079

Review 4.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

Authors:  Phillip I Tarr; Carrie A Gordon; Wayne L Chandler
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

5.  Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome.

Authors:  Wayne L Chandler; Srdjan Jelacic; Daniel R Boster; Marcia A Ciol; Glyn D Williams; Sandra L Watkins; Takashi Igarashi; Phillip I Tarr
Journal:  N Engl J Med       Date:  2002-01-03       Impact factor: 91.245

6.  Community outbreak of hemolytic uremic syndrome attributable to Escherichia coli O111:NM--South Australia 1995.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-07-28       Impact factor: 17.586

7.  Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying shiga toxin-producing Escherichia coli.

Authors:  Rajal K Mody; Ruth E Luna-Gierke; Timothy F Jones; Nicole Comstock; Sharon Hurd; Joni Scheftel; Sarah Lathrop; Glenda Smith; Amanda Palmer; Nancy Strockbine; Deborah Talkington; Barbara E Mahon; Robert M Hoekstra; Patricia M Griffin
Journal:  Arch Pediatr Adolesc Med       Date:  2012-10

8.  Strength of the association between antibiotic use and hemolytic uremic syndrome following Escherichia coli O157:H7 infection varies with case definition.

Authors:  Gillian A M Tarr; Hanna N Oltean; Amanda I Phipps; Peter Rabinowitz; Phillip I Tarr
Journal:  Int J Med Microbiol       Date:  2018-06-26       Impact factor: 3.473

9.  Strategies for surveillance of pediatric hemolytic uremic syndrome: Foodborne Diseases Active Surveillance Network (FoodNet), 2000-2007.

Authors:  Kanyin L Ong; Mirasol Apostal; Nicole Comstock; Sharon Hurd; Tameka Hayes Webb; Stephanie Mickelson; Joni Scheftel; Glenda Smith; Beletshachew Shiferaw; Effie Boothe; L Hannah Gould
Journal:  Clin Infect Dis       Date:  2012-06       Impact factor: 9.079

Review 10.  Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS).

Authors:  Johanna Scheiring; Sharon P Andreoli; Lothar Bernd Zimmerhackl
Journal:  Pediatr Nephrol       Date:  2008-08-13       Impact factor: 3.714

View more
  2 in total

1.  Predicting Hemolytic Uremic Syndrome and Renal Replacement Therapy in Shiga Toxin-producing Escherichia coli-infected Children.

Authors:  Ryan S McKee; David Schnadower; Phillip I Tarr; Jianling Xie; Yaron Finkelstein; Neil Desai; Roni D Lane; Kelly R Bergmann; Ron L Kaplan; Selena Hariharan; Andrea T Cruz; Daniel M Cohen; Andrew Dixon; Sriram Ramgopal; Annie Rominger; Elizabeth C Powell; Jennifer Kilgar; Kenneth A Michelson; Darcy Beer; Martin Bitzan; Christopher M Pruitt; Kenneth Yen; Garth D Meckler; Amy C Plint; Stuart Bradin; Thomas J Abramo; Serge Gouin; April J Kam; Abigail Schuh; Fran Balamuth; Tracy E Hunley; John T Kanegaye; Nicholas E Jones; Usha Avva; Robert Porter; Daniel M Fein; Jeffrey P Louie; Stephen B Freedman
Journal:  Clin Infect Dis       Date:  2020-04-10       Impact factor: 9.079

2.  Farm animal contact is associated with progression to Hemolytic uremic syndrome in patients with Shiga toxin-producing Escherichia coli - Indiana, 2012-2018.

Authors:  Madhura S Vachon; Myda Khalid; Gillian A M Tarr; Craig Hedberg; Jennifer A Brown
Journal:  One Health       Date:  2020-09-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.